A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol.
Kobe J Med Sci
; 63(4): E109-E112, 2018 Apr 19.
Article
en En
| MEDLINE
| ID: mdl-29955022
ABSTRACT
Congenital complete atrioventricular block (CCAVB) is a condition in which the atria and ventricles beat independently of each other. CCAVB cases require permanent pacemaker implantation until adulthood. Nevertheless, consensus regarding postnatal medical therapy for bradycardia has not been reached. Here we report the case of a newborn with CCAVB, whose intractable bradycardia was successfully treated with transdermal tulobuterol. Tulobuterol is a selective ß2-adrenoceptor agonist, widely used safely as bronchodilator in children. It also has positive inotropic and chronotropic effect via ß1-adrenoceptors. We believe the tulobuterol patch can be used as an optional therapy for CCAVB where pacemaker implantation is not available.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Terbutalina
/
Agonistas Adrenérgicos beta
/
Bloqueo Atrioventricular
Límite:
Adult
/
Female
/
Humans
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Kobe J Med Sci
Año:
2018
Tipo del documento:
Article
País de afiliación:
Japón